Evogene outlines ChemPass AI-driven strategy and anticipates new collaborations amid organizational realignment
Source: SeekingAlpha
2026-03-05 16:47:03 ET
More on Evogene
- Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Evogene
- Historical earnings data for Evogene
- Financial information for Evogene
Read the full article on Seeking Alpha
For further details see:
Evogene outlines ChemPass AI-driven strategy and anticipates new collaborations amid organizational realignment
Evogene Ltd.
NASDAQ: EVGN
EVGN Trading
-5.75% G/L:
$0.8002 Last:
2,058 Volume:
$0.8002 Open:
EVGN Latest News
EVGN Stock Data
$6,644,881
6,267,035
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
IL
Rehovot
